If you have ever reduced your corticosteroid dose without consulting your specialist, or stopped because you were afraid they would “harm you,” you are not alone. I see it every week in my practice: many women with vulvar lichen sclerosus arrive with uncontrolled inflammation not because their treatment does not work, but because fear of corticosteroids has led them to use less than they needed. That fear has a name: corticophobia in lichen sclerosus. And it can harm you as much as not treating the disease.
What is corticophobia in vulvar lichen sclerosus?
Corticophobia is the fear of using topical corticosteroids even when they are medically indicated. It is not irrational: it stems from warnings in package leaflets, previous experiences with oral or systemic corticosteroids, or incomplete information found online. The problem is that, in VLS, this fear has direct clinical consequences.
According to the guidelines of the ISSVD (International Society for the Study of Vulvovaginal Disease) and the consensus published in the specialist literature, the cornerstone treatment for vulvar lichen sclerosus is regular application of high-potency topical corticosteroids under the specialist’s indication and follow-up. To date, there is no validated first-line substitute for controlling active inflammation.
Undertreatment: when using less corticosteroid makes things worse
There is a widespread belief: “If I use little corticosteroid, at least I won’t harm myself.” In VLS, that logic fails. Using less corticosteroid than needed does not always protect the skin; sometimes it leaves it exposed to more inflammation. And in vulvar lichen sclerosus, persistent inflammation is one of the recognized causes of disease progression.
~2%
risk of vulvar squamous cell carcinoma associated with long-term uncontrolled VLS, according to data from the specialist literature (Consultant in PubMed on VLS epidemiology).
80–90%
of patients with VLS experience significant clinical improvement with high-potency topical corticosteroids applied according to medical instructions (ISSVD Clinical Guidelines, review literature 2020–2023).
What concerns me is not that someone has questions about a medication. Questions are healthy and should be addressed with the specialist. What concerns me is when that doubt leads to stopping treatment on one’s own, without consulting, and the inflammation remains active month after month without the patient realizing it.
How to use topical corticosteroids correctly in VLS
The key is not to avoid corticosteroids. The key is to use them correctly. This means four specific things:
- Follow the regimen prescribed by your specialist. There is no universal formula. The frequency, application area, and duration are determined by the clinician who knows your case.
- Use the right amount. Neither more nor less. Excessive application also carries risks, but insufficient use leaves the inflammation active.
- Use them for the prescribed duration. Many patients stop treatment as soon as symptoms improve. That does not mean the inflammation has disappeared.
- Attend regular medical follow-ups. Long-term follow-up is essential to adjust the regimen, detect skin changes, and assess whether an additional therapeutic step is needed.
If conventional topical corticosteroids are not sufficient to control your VLS, or if the disease has progressed anatomically, complementary therapeutic options exist. At Liquenia we work with the Liquenia® Protocol (SVF + autologous nanofat), which does not replace but rather integrates into the overall management of the disease when the case requires it.
“What I explain to my patients is that fear of corticosteroids, when it turns into undertreatment, can promote exactly what we want to avoid: disease progression. The most important tool in managing VLS remains specialized medical follow-up, with or without corticosteroids.”
— Dr. Patricia Gutiérrez Ontalvilla, MD, PhD. Specialist in Vulvar Lichen Sclerosus. dragutierrez.com
Do you have questions about your treatment, or have you stopped it out of fear?
Do not make that decision on your own. A specialist assessment can make a difference in the long-term control of your VLS. Request your consultation confidentially.
Frequently asked questions about corticophobia and corticosteroids in VLS
What is corticophobia in vulvar lichen sclerosus?
Corticophobia is the fear of using topical corticosteroids even when they are medically prescribed. In VLS it leads to undertreatment: inflammation is not adequately controlled, which can promote disease progression. It is more common than it seems and is addressed with information and specialist follow-up.
Is it dangerous to stop corticosteroids on my own if I have lichen sclerosus?
It can be. In VLS, stopping treatment without medical supervision can leave inflammation active without you realizing it. Persistent inflammation is one of the recognized factors in disease progression. Any change to the regimen should always be discussed with the specialist managing your case.
Do topical corticosteroids for VLS cause serious side effects?
High-potency topical corticosteroids, used according to medical instructions, in the correct amount, and with periodic check-ups, have an acceptable safety profile in the treatment of VLS. The risk of relevant adverse effects increases with excessive or unsupervised use, not with properly supervised use. Specialist follow-up is key.
How long do I need to use corticosteroids for vulvar lichen sclerosus?
There is no single duration: it depends on each patient, the stage of the disease, and the response to treatment. What is clear is that long-term follow-up is essential. Your specialist determines the regimen and may adjust it over time. Stopping without consulting can reactivate inflammation.
What options are available if corticosteroids are not enough to control my VLS?
When treatment with topical corticosteroids does not sufficiently control the disease, or when established anatomical changes are present, complementary options such as the Liquenia® Protocol (SVF + autologous nanofat) may be considered. This decision always requires an individualized medical assessment. Daily topical vulvar care with products specifically for sensitive skin, such as those from Dermnix, can accompany medical treatment, although it does not replace it.
Dr. Patricia Gutiérrez Ontalvilla, MD, PhD. Plastic surgeon and doctor of medicine. Specialist in vulvar lichen sclerosus and principal investigator of the Liquenia® Protocol (SVF + autologous nanofat). President of the Nixarian Foundation. More information at dragutierrez.com.
